Current studies on DNA-based health tests (e.g., for nutrition, sleep, or caffeine metabolism) indicate they can offer useful insights but are not diagnostic. An RCT (PMC13026531) showed that personalized nutrition based on genetic risk profiles led to modest weight loss, but effect sizes were small and population-specific. The CYP1A2 test (rs762551) predicts caffeine metabolism only partially; lifestyle, liver function, and drugs can override genotype. The PER1 gene (circadian rhythm) is linked to cancer risk, but clinical utility for individual testing remains unclear. Taste plasticity (PMC12030297) further demonstrates that genes are not deterministic – environment and habits matter. Overall, DNA tests may motivate behavior change, but evidence is often moderate and not robust for all markers. Consumers should be cautious of exaggerated claims.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-0ccb40b8db410a79a4d9a188